Profile
I am an epidemiologist specializing in the application of precision medicine approaches in globally diverse datasets to address health inequalities, particularly around cardiometabolic disease. I was previously Associate Professor at LSHTM, where I completed a postdoctoral fellowship funded by the Wellcome Trust examining ethnic inequalities in the care and outcomes of type 2 diabetes, and a member of the OpenSAFELY collaborative working on a range of COVID-19 related projects.
At QMUL, I work in the Clinical Effectiveness Group as part of the Precision Medicine Part 2 program funded by Barts Charity. I am a member of the Genes & Health Executive, where I lead a workstream on developing phenotypes in electronic health record datasets linked to the G&H cohort, and work collaboratively across the WIPH centres on a range of projects focussed on health inequalities.
External engagement and enterprise as relevant:
Member of Diabetes UK Research Steering Groups
Chair of the Membership Committee for the International Society of Pharmacoepidemiology
Member of the South Asian Health Foundation
Research
Research Interests:
I am interested in the application of causal approaches, observational epidemiology, and pharmacoepidemiology using large-scale routine electronic health data to inform best clinical practice, guidelines, and policy.
Supervision
- Binur Orazumbekova, Wellcome Trust, Ethnic variations in risk trajectories for type 2 diabetes: an observational research study combining genetic, cohort, and electronic health record data in the UK
- Elizabeth Remfry, Wellcome Trust, Using artificial intelligence to examine the trajectories of multiple long-term conditions through the lens of inequalities
- Sam Hodgson, Wellcome Trust, Understanding physical/mental health multimorbidity in underrepresented populations